BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 28416122)

  • 1. Patients with a resected pancreatic mucinous cystic neoplasm have a better prognosis than patients with an intraductal papillary mucinous neoplasm: A large single institution series.
    Griffin JF; Page AJ; Samaha GJ; Christopher A; Bhaijee F; Pezhouh MK; Peters NA; Hruban RH; He J; Makary MA; Lennon AM; Cameron JL; Wolfgang CL; Weiss MJ
    Pancreatology; 2017; 17(3):490-496. PubMed ID: 28416122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms of the pancreas differentiated by ovarian-type stroma.
    Murakami Y; Uemura K; Ohge H; Hayashidani Y; Sudo T; Sueda T
    Surgery; 2006 Sep; 140(3):448-53. PubMed ID: 16934608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucinous cystic neoplasm of the pancreas: is surgical resection recommended for all surgically fit patients?
    Park JW; Jang JY; Kang MJ; Kwon W; Chang YR; Kim SW
    Pancreatology; 2014; 14(2):131-6. PubMed ID: 24650968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathological features and prognoses of intraductal papillary mucinous neoplasm and mucinous cystic neoplasm after surgical resection: a single institution series.
    Li Y; Zhu Z; Peng L; Jin Z; Sun L; Song B
    World J Surg Oncol; 2020 Nov; 18(1):287. PubMed ID: 33148260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Undifferentiated Solitary Mucinous Cystic Lesion of the Pancreas: A Clinical Dilemma.
    Roch AM; Bigelow K; Schmidt CM; Carr RA; Jester AL; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    J Am Coll Surg; 2017 Apr; 224(4):717-723. PubMed ID: 28126546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive intraductal papillary mucinous neoplasms and mucinous cystic neoplasms: recurrence rates and postoperative imaging follow-up.
    Xourafas D; Tavakkoli A; Clancy TE; Ashley SW
    Surgery; 2015 Mar; 157(3):473-83. PubMed ID: 25596773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nature and management of pancreatic mucinous cystic neoplasm (MCN): A systematic review of the literature.
    Nilsson LN; Keane MG; Shamali A; Millastre Bocos J; Marijinissen van Zanten M; Antila A; Verdejo Gil C; Del Chiaro M; Laukkarinen J
    Pancreatology; 2016; 16(6):1028-1036. PubMed ID: 27681503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Preoperative Risk Factors With Malignancy in Pancreatic Mucinous Cystic Neoplasms: A Multicenter Study.
    Postlewait LM; Ethun CG; McInnis MR; Merchant N; Parikh A; Idrees K; Isom CA; Hawkins W; Fields RC; Strand M; Weber SM; Cho CS; Salem A; Martin RC; Scoggins C; Bentrem D; Kim HJ; Carr J; Ahmad S; Abbott DE; Wilson GC; Kooby DA; Maithel SK
    JAMA Surg; 2017 Jan; 152(1):19-25. PubMed ID: 27760255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis.
    Marchegiani G; Mino-Kenudson M; Ferrone CR; Warshaw AL; Lillemoe KD; Fernández-del Castillo C
    J Am Coll Surg; 2015 May; 220(5):839-44. PubMed ID: 25840549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic Cystic Tumors: A Single-Center Observational Study.
    Jabłońska B; Gudz A; Hinborch T; Bujała B; Biskup K; Mrowiec S
    Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837443
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
    Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
    Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of steroidogenic enzymes in ovarian-type stroma of pancreatic mucinous cystic neoplasms: Comparative study of subepithelial stromal cells in intraductal papillary mucinous neoplasms of the pancreas.
    Ishida K; Sasano H; Moriya T; Takahashi Y; Sugimoto R; Mue Y; Murakami K; Fujishima F; Nakamura Y; Morikawa T; Motoi F; Suzuki T; Unno M; Sugai T
    Pathol Int; 2016 May; 66(5):281-7. PubMed ID: 27060902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis.
    Reid MD; Stallworth CR; Lewis MM; Akkas G; Memis B; Basturk O; Adsay V
    Cancer Cytopathol; 2016 Feb; 124(2):122-34. PubMed ID: 26415076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics.
    Crippa S; Fernández-Del Castillo C; Salvia R; Finkelstein D; Bassi C; Domínguez I; Muzikansky A; Thayer SP; Falconi M; Mino-Kenudson M; Capelli P; Lauwers GY; Partelli S; Pederzoli P; Warshaw AL
    Clin Gastroenterol Hepatol; 2010 Feb; 8(2):213-9. PubMed ID: 19835989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
    Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
    Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical features and prognosis of intraductal papillary mucinous neoplasms of pancreas: analysis of 38 cases].
    Lou WH; Wang DS; Ji Y; Xu XF; Kuang TT; Ni XL; Wu WC; Jin DY
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):947-50. PubMed ID: 16759531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of recurrence and long-term outcomes in patients who underwent pancreatectomy for intraductal papillary mucinous neoplasms with high grade dysplasia: implications for surveillance and future management guidelines.
    Blackham AU; Doepker MP; Centeno BA; Springett G; Pimiento JM; Malafa M; Hodul PJ
    HPB (Oxford); 2017 Jul; 19(7):603-610. PubMed ID: 28495434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic characteristics of 29 invasive carcinomas arising in 178 pancreatic mucinous cystic neoplasms with ovarian-type stroma: implications for management and prognosis.
    Jang KT; Park SM; Basturk O; Bagci P; Bandyopadhyay S; Stelow EB; Walters DM; Choi DW; Choi SH; Heo JS; Sarmiento JM; Reid MD; Adsay V
    Am J Surg Pathol; 2015 Feb; 39(2):179-87. PubMed ID: 25517958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic Mucinous Cystic Neoplasm Communicating with Main Pancreatic Duct: An Unrecognized Presentation of Pancreatic Mucinous Neoplasm?
    Zhou W; Saam T; Zhou Y; Trevino J; Liu X; Cao D; Lai J
    Anticancer Res; 2017 Dec; 37(12):7017-7021. PubMed ID: 29187489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.